Diabetes Mellitus as a Risk Factor for High Grade Renal Cell Carcinoma

被引:11
|
作者
Otunctemur, Alper [1 ]
Ozbek, Emin [3 ]
Sahin, Suleyman [1 ]
Dursun, Murat [2 ]
Besiroglu, Huseyin [1 ]
Koklu, Ismail [1 ]
Erkoc, Mustafa [1 ]
Danis, Eyyup [1 ]
Bozkurt, Muammer [1 ]
Gurbuz, Ahmet [1 ]
机构
[1] Okmeydani Training & Res Hosp, Dept Urol, Istanbul, Turkey
[2] Okmeydani Training & Res Hosp, Dept Urol, Istanbul, Turkey
[3] Katip Celebi Univ, Ataturk Training & Res Hosp, Dept Urol, Izmir, Turkey
关键词
Diabetes; renal cell carcinoma; tumor size; Furhman grade; HgA1c; KIDNEY CANCER; COHORT; EXPRESSION; RECEPTOR; DISEASE; MEN;
D O I
10.7314/APJCP.2014.15.9.3993
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Diabetes is a chronic disease characterized by impaired fasting blood glucose that leads to disturbances in various organs. In this study, we evaluated relationships between tumor size and grade in a population of diabetic and non-diabetic patients with renal cell carcinoma. Materials and Methods: Between 2007-2013, in our clinic radical nephrectomy performed to 310 patients for renal tumors and pathology reported renal cell carcinoma cases were enrolled in the study. Patients with and without a history of diabetes regarding fasting glucose and HgA1c levels were evaluated during surgery for tumor size and Fuhrman grade. Results: Diabetes was found in 95 patients. The mean age of the patients with and without diabetes mellitus was 64.3 (40-79) and 58.4 (31-87) years, respectively. In the diabetes group 51% of patients had a tumor size over 7 cm and 54% a tumor grade over Fuhrman 3. The respective figures in the non-diabetes group were 35% and 30% (p<0.05 in both cases). Conclusions: Renal cancer appears more aggressive in patients with diabetes. In this study lifestyle and risk factors with diabetes regulation were observed to be important for renal cancer patients. Multicenter studies are needed in larger series for more accurate results.
引用
收藏
页码:3993 / 3996
页数:4
相关论文
共 50 条
  • [21] Genetic variants in macrophage colony-stimulating factor are associated with risk of renal cell carcinoma in a Chinese population
    Li, Xiao
    Qin, Zhiqiang
    Xue, Jianxin
    Zhang, Jianzhong
    Zheng, Yuxiao
    Xu, Weizhang
    Xu, Ting
    Zou, Qing
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2018, 33 (03) : 321 - 328
  • [22] The relationship between blood pressure and risk of renal cell carcinoma
    Alcala, Karine
    Mariosa, Daniela
    Smith-Byrne, Karl
    Nesheli, Dariush Nasrollahzadeh
    Carreras-Torres, Robert
    Aicua, Eva Ardanaz
    Bondonno, Nicola P.
    Bonet, Catalina
    Brunstrom, Mattias
    Bueno-de-Mesquita, Bas
    Chirlaque, Maria-Dolores
    Christakoudi, Sofia
    Heath, Alicia K.
    Kaaks, Rudolf
    Katzke, Verena
    Krogh, Vittorio
    Ljungberg, Borje
    Martin, Richard M.
    May, Anne
    Melander, Olle
    Palli, Domenico
    Rodriguez-Barranco, Miguel
    Sacerdote, Carlotta
    Stocks, Tanja
    Tjonneland, Anne
    Travis, Ruth C.
    Vermeulen, Roel
    Chanock, Stephen
    Purdue, Mark
    Weiderpass, Elisabete
    Muller, David
    Brennan, Paul
    Johansson, Mattias
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2022, 51 (04) : 1317 - 1327
  • [23] Diabetes mellitus in peripheral artery disease: Beyond a risk factor
    Singh, Madhu V.
    Dokun, Ayotunde O.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [24] Claspin overexpression is associated with high-grade histology and poor prognosis in renal cell carcinoma
    Kobayashi, Go
    Sentani, Kazuhiro
    Babasaki, Takashi
    Sekino, Yohei
    Shigematsu, Yoshinori
    Hayashi, Tetsutaro
    Oue, Naohide
    Teishima, Jun
    Matsubara, Akio
    Sasaki, Naomi
    Yasui, Wataru
    CANCER SCIENCE, 2020, 111 (03) : 1020 - 1027
  • [25] Risk factor for clear cell renal cell carcinoma in Chinese population: A case-control study
    Wang, Guoping
    Hou, Jianguo
    Ma, Liye
    Xie, Jiaxin
    Yin, Jianhua
    Xu, Danfeng
    Chang, Wenjun
    Tan, Xiaojie
    Su, Tong
    Zhang, Hongwei
    Cao, Guangwen
    CANCER EPIDEMIOLOGY, 2012, 36 (02) : 177 - 182
  • [26] Diabetes Mellitus and Renal Cell Carcinoma - A Hospital Based Study from Kathmandu Valley
    Gupta, Satrudhan Pd
    Mittal, Ankush
    Jha, Dipendra Kumar
    Pandeya, Dipendra Raj
    Sathian, Brijesh
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (10) : 4963 - 4965
  • [27] Carbonic anhydrase 10 functions as a tumor suppressor in renal cell carcinoma and its methylation is a risk factor for survival outcome
    Li, Qinhan
    Zhang, Lian
    Zhang, Zhenan
    Fan, Yu
    Zhang, Qian
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (04) : 168.e1 - 168.e9
  • [28] Diabetes mellitus: a risk factor for pancreatic cancer?
    M. Yalniz
    P. M. Pour
    Langenbeck's Archives of Surgery, 2005, 390 : 66 - 72
  • [29] Diabetes mellitus: a risk factor for pancreatic cancer?
    Yalniz, M
    Pour, PM
    LANGENBECKS ARCHIVES OF SURGERY, 2005, 390 (01) : 66 - 72
  • [30] Risk of acute renal failure in patients with Type 2 diabetes mellitus
    Girman, C. J.
    Kou, T. D.
    Brodovicz, K.
    Alexander, C. M.
    O'Neill, E. A.
    Engel, S.
    Williams-Herman, D. E.
    Katz, L.
    DIABETIC MEDICINE, 2012, 29 (05) : 614 - 621